Caribou Biosciences (CRBU)
(Delayed Data from NSDQ)
$1.87 USD
+0.08 (4.47%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $1.86 -0.01 (-0.53%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.44 |
EPS Last Quarter | -0.42 |
Last EPS Surprise | 6.67% |
ABR | 1.56 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.76 |
Next Year | -2.01 |
EPS (TTM) | -1.39 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.37M | 3.83M | 11.30M | 13.60M |
# of Estimates | 3 | 3 | 4 | 3 |
High Estimate | 4.12M | 6.39M | 16.40M | 16.81M |
Low Estimate | 2.50M | 1.60M | 5.90M | 10.00M |
Year ago Sales | 23.66M | 3.56M | 34.48M | 11.30M |
Year over Year Growth Est. | -85.74% | 7.58% | -67.23% | 20.41% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.44 | -0.45 | -1.76 | -2.01 |
# of Estimates | 4 | 4 | 6 | 5 |
Most Recent Consensus | -0.44 | -0.46 | -1.79 | -2.00 |
High Estimate | -0.41 | -0.45 | -1.65 | -1.69 |
Low Estimate | -0.45 | -0.46 | -1.79 | -2.92 |
Year ago EPS | -0.12 | -0.39 | -1.38 | -1.76 |
Year over Year Growth Est. | -266.67% | -15.38% | -27.54% | -14.62% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 4 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.44 | -0.45 | -1.76 | -2.01 |
7 Days Ago | -0.44 | -0.45 | -1.76 | -2.01 |
30 Days Ago | -0.44 | -0.45 | -1.76 | -2.01 |
60 Days Ago | -0.46 | -0.49 | -1.80 | -2.06 |
90 Days Ago | -0.47 | -0.49 | -1.80 | -2.10 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.44 | -0.45 | -1.76 | -2.01 |
Zacks Consensus Estimate | -0.44 | -0.45 | -1.76 | -2.01 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.42 | -0.46 | -0.39 | -0.12 | NA |
Estimate | -0.45 | -0.39 | -0.22 | -0.38 | NA |
Difference | 0.03 | -0.07 | -0.17 | 0.26 | 0.01 |
Surprise | 6.67% | -17.95% | -77.27% | 68.42% | -5.03% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more